← Back to explorer

2024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP]

TED · 445958-2026can-standardawardedNo deadline given

Buyer

NameUnidade Local de Saúde Santa Maria, E.P.E.

CountryPT

Published2026-06-30

Deadline—

Value

Estimated€232,560 · 232,560 EUR

Awarded—

WinnerVIIVHIV HEALTHCARE, UNIPESSOAL, LDA

See this firm's wins →

Who already wins at this buyer

Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.

FirmWinsAwardedLast win
ROCHE Farmacêutica Química, LDA11—2026-06-09
GILEAD SCIENCES, LDA10—2026-05-27
NOVARTIS FARMA - PROD.FARM SA9—2026-06-30
AMGEN BIOFARMACEUTICA, LDA8€396,6442026-06-24
TAKEDA-Farmaceuticos Portugal, Lda6€554,7602026-06-24

Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP]

Similar tenders

Closest by meaning — across languages, via embeddings.

PublishedTitleBuyerMatch
2026-06-302024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT100%
2026-06-302024/0900 - DOLUTEGRAVIR [50 MG CÁP/COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT97%
2026-05-122024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT97%
2026-05-272024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT95%
2026-05-272024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT95%
2026-05-122025/1589 - MARIBAVIR [200 MG COMP]Unidade Local de Saúde Santa Maria, E.P.E. PT94%

Source

View the official notice on TED ↗